RTCT catalyst
Why FDA’s real-time clinical trials announcement changes the clinical operations conversation.
New white paper | May 2026
Trial Telemetry for Clinical Trials
Governed signal flow, risk-based assurance, and continuous regulatory readiness after FDA’s real-time clinical trials announcement.
White paper
A governed signal layer for modern clinical trials.
This white paper introduces Trial Telemetry as the governed signal layer for modern clinical trials with several diagrams to facilitate the concepts.
It connects FDA’s real-time clinical trials announcement, CSA/CSV modernization, DHT and eSource guidance, AI credibility, and ICH E6(R3) into one practical operating model: trusted signals, accountable workflows, and continuous regulatory readiness.
Why now
Real-time trials need governed signal exchange, not more dashboards.
Most sponsors and CROs already have dashboards. The harder problem is determining whether a displayed metric is trustworthy, current, contextualized, traceable, and fit for action.
Trial Telemetry is not a dashboard project. It is a governed operating model for modern clinical trials.
Inside the paper
What the download covers.
Risk-based assurance
How CSA/CSV modernization reinforces a practical focus on risk, confidence, and critical signals.
C4I + Trust
A control model for ingestion, governance, analysis, execution, and accountability.
Adoption roadmap
How sponsors and CROs can start with one trusted signal pathway and scale over time.
The downloadable paper includes visual models for governed signal flow, C4I + Trust, portfolio awareness, and adoption planning.
Download
Get the Trial Telemetry white paper.
Submit your email to access the PDF. You’ll be redirected to a thank-you page where the download starts automatically, with a manual download button as backup.